We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals

136 hedge funds and large institutions have $489M invested in Amphastar Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 38

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

1% more funds holding

Funds holding: 135136 (+1)

1.88% less ownership

Funds ownership: 57.01%55.13% (-1.9%)

17% less capital invested

Capital invested by funds: $591M → $489M (-$102M)

82% less call options, than puts

Call options by funds: $203K | Put options by funds: $1.11M

Holders
136
Holders Change
+1
Holders Change %
+0.74%
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
55
Reduced
38
Closed
15
Calls
$203K
Puts
$1.11M
Net Calls
-$903K
Net Calls Change
+$1.46M
Name Holding Trade Value Shares
Change
Change in
Stake
Voloridge Investment Management
51
Voloridge Investment Management
Florida
$854K +$917K +45,541 New
UBS AM
52
UBS AM
Illinois
$770K +$71.3K +3,540 +9%
Comerica Bank
53
Comerica Bank
Texas
$768K +$47K +2,335 +7%
Canada Life
54
Canada Life
Manitoba, Canada
$760K -$16.6K -824 -2%
CS
55
Credit Suisse
Switzerland
$719K -$34.6K -1,717 -4%
JCIA
56
Jackson Creek Investment Advisors
Colorado
$686K +$737K +36,590 New
SFI
57
Susquehanna Fundamental Investments
Pennsylvania
$683K -$44.3K -2,200 -6%
Susquehanna International Group
58
Susquehanna International Group
Pennsylvania
$654K +$257K +12,743 +58%
SOADOR
59
State of Alaska Department of Revenue
Alaska
$641K +$48.3K +2,400 +8%
TPSF
60
Texas Permanent School Fund
Texas
$640K +$151K +7,509 +28%
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$602K
Thrivent Financial for Lutherans
62
Thrivent Financial for Lutherans
Minnesota
$568K +$42.1K +2,091 +7%
EGM
63
Engineers Gate Manager
New York
$554K -$454K -22,544 -43%
COPPSERS
64
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$532K +$229K +11,397 +67%
WAM
65
Wakefield Asset Management
Colorado
$522K +$2.11K +105 +0.4%
Deutsche Bank
66
Deutsche Bank
Germany
$486K +$34.4K +1,706 +7%
AIG
67
American International Group
New York
$472K +$4.81K +239 +1%
AG
68
Aperio Group
California
$467K +$18.3K +911 +4%
HSBC Holdings
69
HSBC Holdings
United Kingdom
$460K +$14.4K +716 +3%
AIM
70
Aigen Investment Management
New York
$448K +$481K +23,900 New
New York State Teachers Retirement System (NYSTRS)
71
New York State Teachers Retirement System (NYSTRS)
New York
$407K -$34.2K -1,700 -7%
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$407K
GC
73
Globeflex Capital
California
$405K
QI
74
QS Investors
New York
$390K -$969K -48,137 -70%
CIC
75
Cornercap Investment Counsel
Georgia
$390K +$419K +20,790 New

AMPH Hedge Fund Activity: Q3 2020 in Review

136 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2020, worth a combined $489M — down 17% from $591M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AMPH positions and 15 closed out — a net gain of 2 holders — while 55 added to existing stakes and 38 trimmed.

The largest buyer was BlackRock, adding an estimated $5.87M. The largest seller was VOYA Investment Management, cutting an estimated $8.38M.

  • 136 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2020, up from 135 in Q2 2020.
  • Funds reported $489M of Amphastar Pharmaceuticals stock for Q3 2020, down 17% quarter-over-quarter.
  • 17 funds opened new Amphastar Pharmaceuticals positions in Q3 2020 and 15 closed out, a net change of +2 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2020 was BlackRock, an estimated $5.87M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2020 was VOYA Investment Management, an estimated $8.38M sold.

Based on aggregated 13F filings for Q3 2020.